The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Parvolex 200mg/ml concentrate for Solution for Infusion

Phoenix LabsPA1113/008/001

Main Information

Trade NameParvolex 200mg/ml concentrate for Solution for Infusion
Active SubstancesAcetylcysteine
Dosage FormConcentrate for solution for infusion
Licence HolderPhoenix Labs
Licence NumberPA1113/008/001

Group Information

ATC CodeV03AB Antidotes
V03AB23 acetylcysteine


License statusAuthorised
Licence Issued07/07/1993
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back